In preclinical models of allergic asthma, anti-HMGB1 or genetic ablation of RAGE (receptor for advanced glycation endproducts), one of the receptors ligated by HMGB1, is protective [6–8]. This evidence concerns the gene HMGB1 and allergic asthma.